{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:58:37Z","timestamp":1794351517427,"version":"4.9.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jasc.2023.09.007","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:53:56Z","timestamp":1695606836000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The evolution of cervical cancer screening"],"prefix":"10.1016","volume":"13","author":[{"given":"Amy A.","family":"Swanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-5503","authenticated-orcid":false,"given":"Liron","family":"Pantanowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Suppl","key":"10.1016\/j.jasc.2023.09.007_bib1","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1002\/cncr.11380","article-title":"Long-term trends in cancer mortality in the United States, 1930-1998","volume":"97","author":"Wingo","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2023.09.007_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1159\/000328553","article-title":"The century for cytopathology","volume":"44","author":"Naylor","year":"2000","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2023.09.007_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0849-5831(16)31416-1","article-title":"The History of Cervical Screening I: The Pap. Test","volume":"22","author":"Shaw","year":"2000","journal-title":"J SOGC"},{"key":"10.1016\/j.jasc.2023.09.007_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000457827","article-title":"Inception and development of the Papanicolaou Stain Method","volume":"61","author":"Chantziantoniou","year":"2017","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2023.09.007_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1309\/MU74MJE9BA8HABDM","article-title":"Cytotechnology: a profession on the move\u2014then and now","volume":"39","author":"Naik","year":"2008","journal-title":"Lab Med"},{"key":"10.1016\/j.jasc.2023.09.007_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e318282b982","article-title":"The evolution of the Papanicolaou smear","volume":"56","author":"Tambouret","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jasc.2023.09.007_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000477556","article-title":"The bethesda system for reporting cervical cytology: a historical perspective","volume":"61","author":"Nayar","year":"2017","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2023.09.007_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jasc.2014.04.004","article-title":"The impact of the Clinical Laboratory Improvement Amendments of 1988 on cytopathology practice: a 25th anniversary review","volume":"3","author":"Davey","year":"2014","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2023.09.007_bib9","first-page":"F55","article-title":"Papillomavirus infections--a major cause of human cancers","volume":"1288","author":"zur Hausen","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jasc.2023.09.007_bib10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jasc.2023.09.007_bib11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1159\/000328554","article-title":"ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants","volume":"44","author":"Schiffman","year":"2000","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2023.09.007_bib12","doi-asserted-by":"crossref","first-page":"946","DOI":"10.5858\/2003-127-946-FTDFTA","article-title":"Findings to date from the ASCUS-LSIL Triage Study (ALTS)","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2023.09.007_bib13","series-title":"New Approaches in the Evaluation for High-Risk Human Papillomavirus Nuclei Acid Detection Devices","year":"2019"},{"key":"10.1016\/j.jasc.2023.09.007_bib14","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 Consensus Guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2023.09.007_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2023.09.007_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2023.09.007_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2023.09.007_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jnci\/djx225","article-title":"Relative performance of HPV and cytology components of cotesting in cervical screening","volume":"110","author":"Schiffman","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2023.09.007_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.09.007_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jasc.2019.06.001","article-title":"A review of the FDA-approved molecular testing platforms for human papillomavirus","volume":"8","author":"Salazar","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2023.09.007_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2023.09.007_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jasc.2017.12.001","article-title":"Primary HPV cervical cancer screening in the United States: are we ready?","volume":"7","author":"Nayar","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2023.09.007_bib23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2023.09.007_bib24","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2023.09.007_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","article-title":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial","volume":"144","author":"Wright","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2023.09.007_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.33812","article-title":"Clinical validation of p16\/Ki-67 dual-stained cytology triage of HPV-positive women: results from the IMPACT trial","volume":"150","author":"Wright","year":"2022","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jasc.2023.09.007_bib27","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jasc.2023.09.007_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.279.3.235","article-title":"PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy","volume":"279","author":"O'Leary","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2023.09.007_bib29","first-page":"45","article-title":"NeoPath, Inc. NeoPath AutoPap 300 Automatic Pap Screener System","volume":"40","author":"Patten","year":"1996","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2023.09.007_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000508629","article-title":"Computational cytology: lessons learned from pap test computer-assisted screening","volume":"65","author":"Lew","year":"2021","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2023.09.007_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/dc.23931","article-title":"Automated screening of Papanicolaou tests: a review of the literature","volume":"47","author":"Thrall","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2023.09.007_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cncy.22561","article-title":"Improving the Pap test with artificial intelligence","volume":"130","author":"Pantanowitz","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.09.007_bib33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jasc.2019.03.003","article-title":"Artificial intelligence in cytopathology: a review of the literature and overview of commercial landscape","volume":"8","author":"Landau","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2023.09.007_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmpb.2018.05.034","article-title":"A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images","volume":"164","author":"William","year":"2018","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jasc.2023.09.007_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations -United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"issue":"Suppl 1","key":"10.1016\/j.jasc.2023.09.007_bib36","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcv.2015.11.020","article-title":"Cervical cancer screening of HPV vaccinated populations: cytology, molecular testing, both or none","volume":"76","author":"El-Zein","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jasc.2023.09.007_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002388","article-title":"Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial","volume":"14","author":"Canfell","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.jasc.2023.09.007_bib39","doi-asserted-by":"crossref","DOI":"10.17061\/phrp2921914","article-title":"Lessons from the renewal of the National Cervical Screening Program in Australia","volume":"29","author":"Smith","year":"2019","journal-title":"Public Health Res Pract"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294523002296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294523002296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:47:48Z","timestamp":1761979668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294523002296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213294523002296"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2023.09.007","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolution of cervical cancer screening","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2023.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}